Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pharming Group N.V (PHAR) Total Liabilities: 2019-2025

Historic Total Liabilities for Pharming Group N.V (PHAR) over the last 5 years, with Sep 2025 value amounting to $473.8 million.

  • Pharming Group N.V's Total Liabilities rose 11.34% to $473.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year decrease of 1.30%. This contributed to the annual value of $178.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Pharming Group N.V's Total Liabilities is $473.8 million, which was up 6.17% from $446.3 million recorded in Q2 2025.
  • Pharming Group N.V's 5-year Total Liabilities high stood at $473.8 million for Q3 2025, and its period low was $165,000 during Q4 2021.
  • Over the past 3 years, Pharming Group N.V's median Total Liabilities value was $429.8 million (recorded in 2023), while the average stood at $432.6 million.
  • Per our database at Business Quant, Pharming Group N.V's Total Liabilities tumbled by 99.90% in 2022 and then soared by 114,061.85% in 2023.
  • Pharming Group N.V's Total Liabilities (Quarterly) stood at $165,000 in 2021, then tumbled by 99.90% to $382,323 in 2022, then soared by 114,061.85% to $462.9 million in 2023, then declined by 13.58% to $400.0 million in 2024, then grew by 11.34% to $473.8 million in 2025.
  • Its Total Liabilities was $473.8 million in Q3 2025, compared to $446.3 million in Q2 2025 and $403.2 million in Q1 2025.